Jorma Hinkula
0000-0003-1908-5609
Karolinska Institute
153 papers found
Refreshing results…
Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17.
Peptides isolated from random peptide libraries on phage elicit a neutralizing anti-HIV-1 response: analysis of immunological mimicry.
Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1
Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cells
Antibody-dependent cellular cytotoxicity to clinical isolates of HIV-1 and SIVcpz: comparison of humans and chimpanzees:
Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160
Immune responses to the HIV rev regulatory gene.
Nucleic Acid Vaccination with HIV Regulatory Genes
Antibody prevalence and immunoglobulin IgG subclass pattern to norwalk virus in Sweden
Monoclonal antibodies to p24-core protein of HIV-1 mediate ADCC and inhibit virus spread in vitro
Molecular characterization of a human anti-HIV 1 monoclonal antibody revealed a CD26-related motif in CDR2
Mimicking the humoral immune response in vitro results in antigen‐specific isotype switching supported by specific autologous T helper cells: generation of human HIV‐1‐neutralizing IgG monoclonal antibodies from naive donors
Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule
Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160
Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies
Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems
Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope.
Inhibition of viral replication by monoclonal antibodies directed against human immunodeficiency virus gp120
Missing publications? Search for publications with a matching author name.